Reinier de Graaf Groep — Clinical Trial Site

69 Registered trials

29 Currently recruiting

Organisation

Reinier de Graaf Groep

Location

Delft, Netherlands

Identifier

ORG-100042912

Address

Reinier De Graafweg 5, 2625 AD, Netherlands

Departments

#2303: Oncology
#2924:Cardiology
#3722: Cardiology
2304:Medical Oncology
3722: Cardiology
4002: Cardiology
4301: Oncology
Anesthesiology
Anesthesiology and pain
Cardiology
Department of Medical Oncology
gynaecologie
Gynaecology
Hematologie
Hematology
Intensive Care
interne geneeskunde
Medical oncology
Medische Oncologie
N/A
NEK
Neurology
Oncology
Ophthalmology
Reinier de Graaf Gasthuis, dept. Internal medicine
Reproductive medicine and gynecology
Research cardiologie
Research cardiology
Research department Cardiology
Research Unit Oncology
Surgery
Urology

Clinical trials at this site (69)

Search interface

A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
MetAddon: Methadone as co-analgesic for patients with metastatic bone pain: a double-blind randomized controlled trial Pending

2025-522710-22-00 Cancer, bone metastasis, pain 6
Adjuvant Pembrolizumab in patients with early-stage triple negative breast cancer with residual disease after treatment with chemotherapy an… Pending

2025-524229-41-00 Triple negative breast cancer 5
An open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) Recruiting

2024-519870-38-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-05-11
Adjuvant chemotherapy for prevention of recurrence in patients with detectable ctDNA after surgery in high-riskrectal cancer. Recruiting

2024-517700-12-00 Rectal cancer 5 2025-12-10
A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting

2024-512733-32-00 Acute Myeloid Leukemia (AML) 5 2025-03-31
(PREVENT)A Randomized, Double-blind, Placebo-controlled Trial on the Prevention of Chronic Postoperative Pain after Inguinal Hernia and Knee… Recruiting

2024-511010-21-00 chronic postoperative pain 6 2024-07-22
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants with Early Breast Cancer (EMBER-4) Recruiting

2022-501007-28-00 Breast Neoplasms 5 2023-04-18
ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting

2025-522960-34-00 Established cardiovascular disease 5 2026-02-09
A Study to Learn About the Investigational Medicine Called Mevrometostat (PF-06821497) in Men With Metastatic Castration-Sensitive Prostate … Recruiting

2024-519369-24-00 METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER 5 2026-01-29
A study to investigate the efficacy, safety, tolerability and pharmacokinetics of PKN605 in participants with atrial fibrillation Recruiting

2025-520518-79-00 Atrial Fibrillation 4 2026-01-06
Pasritamig vs Placebo in late line Metastatic Castration-resistant Prostate Cancer (mCRPC) Recruiting

2025-520927-26-00 Metastatic Castration-resistant Prostate Cancer (mCRPC) 5 2025-11-24
A Study to Learn About the Study Medicine Called PF-07248144 in Combination with Fulvestrant in People with HR-positive, HER2-negative Advan… Recruiting

2025-520566-22-00 Hormone Receptor-Positive, HER2-Negative Advanced/Metas 5 2025-11-10
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and … Recruiting

2024-516652-18-00 Atherosclerotic cardiovascular disease (ASCVD) and obes 5 2025-10-10
BuLLSEYE Recruiting

2024-512950-13-00 Sepsis 11 2025-01-03
Stopping or continuing blood thinners after stroke at young age without a known cause: STOP trial Recruiting

2024-513092-40-00 Stroke 6 2024-12-05
Ulipristal versus surgery for symptomatic uterine fibroids Recruiting

2024-512602-26-00 Uterine fibroids 6 2024-12-02
Oil- based versus water-based contrast media for hysterosalpingography (HSG) in infertile women with unevaluated indications: a randomized c… Recruiting

2024-512571-12-00 Infertility 6 2024-11-29
DOSAgE study: A multicenter randomized phase III trial of DOSe-reduced Chemotherapy for Advanced Colorectal Cancer in Older patients Recruiting

2023-506115-17-00 Metastatic Colorectal Cancer 5 2024-10-14
HOVON 170 DLBCL: ANTICIPATE: Prevention of ANThracycline-Induced Cardiac dysfunction by dexrazoxane In PATients with diffusE large B-cell ly… Recruiting

2023-505377-32-00 Diffuse large B-cell lymphoma (DLBCL) 5 2024-08-15
The RED FLASH study Recruiting

2023-507847-13-00 Breast cancer 5 2024-08-09
FeAsiBility of a treatment free interval in newly diagnosed mUltiple myeLOma patients treated with DaratumUmab-Lenalidomide-DexamethaSone – … Recruiting

2023-508586-33-00 multiple myeloma 5 2024-05-14
RADAR: A randomised phase III trial with a PET response adapted design comparing ABVD +/- ISRT with A2VD +/- ISRT in patients with previousl… Recruiting

2022-500031-37-00 stage IA/IIA Hodgkin lymphoma 5 2024-04-08